Hikma’s Injectables Business Expands As It Completes Custopharm Acquisition

Completion Of $425m Deal Comes Shortly After FTC Approved The Transaction

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.